By:
On:
In: Fair company, Stock analysis
Tagged:
With: 0 Comments

 

Company name China Biologic Products Holdings Inc
Stock ticker CBPO
Live stock price [stckqut]CBPO[/stckqut]
P/E compared to competitors Fair

 

MANAGEMENT EXECUTION

Employee productivity Poor
Sales growth Fair
EPS growth Good
P/E growth Poor
EBIT growth Good
Price growth Good
R&D growth Fair
Income growth Good
Assets growth Good
Return on Assets growth Poor
Income / Rev growth Fair
TWCA Plus Good
Standard TWCA Good
Weighted ann. stock price increase Poor

 

ANALYSIS

Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $169.48
Target stock price (averages with growth) $120.38
Target stock price (averages with no growth) $119.75
Target stock price (manual assumptions) $128.17

 

The following company description is from Reuters: https://finance.yahoo.com/quote/cbpo/profile?p=cbpo

China Biologic Products Holdings, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People’s Republic of China. It offers human albumin for treating shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and nephropathy; and neonatal hyperbilirubinemia, as well as for the prevention and treatment of low-density-lipoproteinemia. The company also provides human immunoglobulin and IVIG for original and secondary immunoglobulin deficiency, and immunoglobulin G secondary deficiency; human hepatitis B immunoglobulin for the prevention of measles and contagious hepatitis; human rabies immunoglobulin primarily for passive immunity from bites or claws by rabies or other infected animals; and human tetanus immunoglobulin for the prevention and therapy of tetanus. In addition, it offers placenta polypeptide for the treatment of cell immunity deficiency diseases, viral infection, and leucopenia, as well as assists in postoperative healing; factor VIII for treating coagulopathies; human fibrinogen; and human prothrombin complex concentrate for treating congenital and acquired clotting factor II, VII, IX, X deficiency, as well as excessive anticoagulant, vitamin K deficiency, etc. Further, the company is developing Human fibrinogen for the treatment for lack of fibrinogen and increase human fibrinogen concentration; and artificial dura and spinal dura mater products for use in brain and spinal surgeries. The company sells its products directly, as well as through distributors. The company was formerly known as China Biologic Products, Inc. and changed its name to China Biologic Products Holdings, Inc. in July 2017. China Biologic Products Holdings, Inc. is headquartered in Beijing, the People’s Republic of China.

 

Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in China Biologic Products Holdings Inc as long as the price is correct and the indicators that I describe in my book The Confident Investor are favorable. Most of the fundamentals of this company are good but there are some concerns. I am removing China Biologic from my Watch List due to its recent stock performance and the current climate of reducing the importance of companies from China in western markets. This will make room for stocks that are higher performing.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor. You can review the best companies that I have found (and I probably invest my own money in most of these companies) in my Watch List.

How was this analysis of China Biologic Products Holdings Inc calculated?

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(access_s2member_level1)]

In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

  • Stock price at the time of the calculation: $109.64
  • Growth: 0.1647
  • Current EPS (TTM): $3.64833333333333
  • P/E: 26.3983823385159
  • Future EPS Calc: $7.81
  • Future Stock Price Calc: $206.41
  • Target stock price: $128.16

[/s2If]
I hope that this makes you a Confident Investor.

By:
On:
In: Good company, Stock analysis
Tagged:
With: 0 Comments

 

Company name Broadcom Inc
Stock ticker AVGO
Live stock price [stckqut]AVGO[/stckqut]
P/E compared to competitors Fair

 

MANAGEMENT EXECUTION

Employee productivity Poor
Sales growth Good
EPS growth Good
P/E growth Good
EBIT growth Good
Price growth Good
R&D growth Good
Income growth Good
Assets growth Good
Return on Assets growth Good
Income / Rev growth Good
TWCA Plus Good
Standard TWCA Good
Weighted ann. stock price increase Good

 

ANALYSIS

Confident Investor Rating Good
Target stock price (TWCA growth scenario) $476.91
Target stock price (averages with growth) $1344.92
Target stock price (averages with no growth) $776.67
Target stock price (manual assumptions) $693.09

The following company description is from Reuters: https://finance.yahoo.com/quote/avgo/profile?p=avgo

Broadcom Inc. designs, develops, and supplies a range of semiconductor devices with a focus on complex digital and mixed signal complementary metal oxide semiconductor based devices and analog III-V based products worldwide. The company operates through three segments: Semiconductor Solutions, Infrastructure Software, and Intellectual Property licensing. It provides set-top box system-on-chips (SoCs); cable, digital subscriber line, and passive optical networking central office/consumer premise equipment SoCs; Wireless local area network access point SoCs; Ethernet switching and routing application specific standard products; embedded processors and controllers; serializer/deserializer application specific integrated circuits; optical and copper, and physical layers; and fiber optic laser and receiver components. The company also offers RF front end modules, filters, and power amplifiers; Wi-Fi, Bluetooth, and global positioning system/global navigation satellite system SoCs; custom touch controllers; serial attached small computer system interface, and redundant array of independent disks controllers and adapters; peripheral component interconnect express switches; fiber channel host bus adapters; read channel based SoCs; custom flash controllers; preamplifiers; and optocouplers, industrial fiber optics, motion control encoders and subsystems, and light emitting diodes. In addition, it provides mainframe and enterprise software solution and cybersecurity solutions. Its products are used in various applications, including enterprise and data center networking, home connectivity, set-top boxes, broadband access, telecommunication equipment, smartphones and base stations, data center servers and storage systems, factory automation, power generation and alternative energy systems, and electronic displays. Broadcom Inc. was incorporated in 2018 and is headquartered in San Jose, California.

 

Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in Broadcom Inc as long as the indicators that I describe in my book The Confident Investor are favorable.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor. You can review the best companies that I have found (and I probably invest my own money in most of these companies) in my Watch List.

How was this analysis of Broadcom Inc calculated?

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(access_s2member_level1)]

In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

  • Stock price at the time of the calculation: $308.89
  • Growth: 0.1745
  • Current EPS (TTM): $9.74
  • P/E: 51.277626877296
  • Future EPS Calc: $21.76
  • Future Stock Price Calc: $1116.22
  • Target stock price: $693.08

[/s2If]
I hope that this makes you a Confident Investor.

By:
On:
In: Good company, Stock analysis
Tagged:
With: 0 Comments

Company name Nexstar Media Group Inc
Stock ticker NXST
Live stock price [stckqut]NXST[/stckqut]
P/E compared to competitors Good

MANAGEMENT EXECUTION

Employee productivity Poor
Sales growth Good
EPS growth Good
P/E growth Good
EBIT growth Good

ANALYSIS

Confident Investor Rating Good
Target stock price (TWCA growth scenario) $114.82
Target stock price (averages with growth) $169.04
Target stock price (averages with no growth) $114.82
Target stock price (manual assumptions) $113.75

The following company description is from Reuters: https://www.reuters.com/finance/stocks/company-profile/nxst

Nexstar Media Group, Inc., formerly Nexstar Broadcasting Group, Inc., incorporated on May 17, 2001, is a television broadcasting and digital media company. The Company is focused on the acquisition, development, and operation of television stations and interactive community Websites, and digital media services in medium-sized markets in the United States. The Company’s segments include Broadcasting and Other. The Company’s broadcast segment includes television stations and related community-focused Websites that it owns, operates, programs or provides sales and other services to various markets across the United States. The other activities of the Company include corporate functions, eliminations, and other operations. As of December 31, 2016, it owned, operated, programmed or provided sales and other services to 104 full-power television stations in 62 markets in the states of Alabama, Arizona, Arkansas, California, Colorado, Florida, Illinois, Indiana, Iowa, Louisiana, Maryland, Michigan, Missouri, Montana, Nevada, New York, North Dakota, Pennsylvania, Tennessee, Texas, Utah, Vermont, Virginia, West Virginia and Wisconsin.

 

Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in Nexstar Media Group Inc as long as the indicators that I describe in my book The Confident Investor are favorable. I will be adding Nexstar to my Watch List.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor. You can review the best companies that I have found (and I probably invest my own money in most of these companies) in my Watch List.

How was this analysis of Nexstar Media Group Inc calculated?

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(access_s2member_level1)]

In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

  • Stock price at the time of the calculation: $74.25
  • Growth: 0.2
  • Current EPS (TTM): $4.09
  • P/E: 18
  • Future EPS Calc: $10.17
  • Future Stock Price Calc: $183.19
  • Target stock price: $113.74

[/s2If]
I hope that this makes you a Confident Investor.

By:
On:
In: Good company, Stock analysis
Tagged:
With: 0 Comments

Company name Coherent, Inc.
Stock ticker COHR
Live stock price [stckqut]COHR[/stckqut]
P/E compared to competitors Good

MANAGEMENT EXECUTION

Employee productivity Poor
Sales growth Good
EPS growth Good
P/E growth Poor
EBIT growth Good

ANALYSIS

Confident Investor Rating Good
Target stock price (TWCA growth scenario) $235.45
Target stock price (averages with growth) $328.94
Target stock price (averages with no growth) $223.44
Target stock price (manual assumptions) $227.48

The following company description is from Reuters: https://www.reuters.com/finance/stocks/company-profile/cohr

Coherent, Inc., incorporated on January 11, 1989, is a photonics manufacturer. The Company is engaged in designing, manufacturing, servicing, and marketing of lasers and related accessories for a range of scientific, commercial and industrial applications. The Company operates through two segments: Specialty Lasers and Systems (SLS) and Commercial Lasers and Components (CLC). The Specialty Lasers and Systems segment develops and manufactures configurable products serving the microelectronics, scientific research and government programs, and original equipment manufacturer (OEM) components and instrumentation markets. The Commercial Lasers and Components segment focuses on higher volume products that are offered in set configurations. The product architectures are designed for exchange at the point of use such that substantially all product service and repairs are based upon advanced replacement and depot (that is factory) repair. CLC’s primary markets include materials processing, OEM components, and instrumentation and microelectronics.

The Company offers a portfolio of carbon dioxide (CO2) and carbon monoxide (CO) lasers, diode laser systems and fiber lasers, laser cutting and machining tools, continuous wave (CW) solid state, diode lasers, diode-pumped solid-state lasers (DPSS), excimer lasers and ultraviolet (UV) beam delivery, ion lasers, three dimensional (3D) profiling lasers, tunable lasers, industrial short-pulse lasers and ultrafast lasers for science. These products address a range of applications, which are grouped into various markets, including microelectronics, materials processing, OEM components and instrumentation, and scientific research and government programs. The markets in the microelectronics industry that are supported by the Company include flat panel display (FPD) manufacturing, advanced packaging and interconnects (API) and semiconductor front-end (SEMI). It manufactures a range of DPSS lasers for different applications, including semiconductor inspection; advanced packaging and interconnects; laser pumping; spectroscopy; bio-agent detection; Deoxyribonucleic acid (DNA) sequencing; drug discovery; flow cytometry; forensics; computer-to-plate printing; entertainment lighting (display); medical; rapid prototyping and marking, welding and engraving.

 

Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in Coherent, Inc. as long as the indicators that I describe in my book The Confident Investor are favorable. I am adding Coherent to my Watch List.

 

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor. You can review the best companies that I have found (and I probably invest my own money in most of these companies) in my Watch List.

How was this analysis of Coherent, Inc. calculated?

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(access_s2member_level1)]

In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

  • Stock price at the time of the calculation: $152.44
  • Growth: 0.19
  • Current EPS (TTM): $8.08
  • P/E: 19
  • Future EPS Calc: $19.28
  • Future Stock Price Calc: $366.35
  • Target stock price: $227.47

[/s2If]
I hope that this makes you a Confident Investor.

By:
On:
In: Fair company, Stock analysis
Tagged:
With: 0 Comments

Company name Thermo Fisher Scientific Inc.
Stock ticker TMO
Live stock price [stckqut]TMO[/stckqut]
P/E compared to competitors Fair

MANAGEMENT EXECUTION

Employee productivity Poor
Sales growth Fair
EPS growth Poor
P/E growth Fair
EBIT growth Good

ANALYSIS

Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $212.03
Target stock price (averages with growth) $268.09
Target stock price (averages with no growth) $217.34
Target stock price (manual assumptions) $212.

The following company description is from Reuters: https://www.reuters.com/finance/stocks/company-profile/tmo

Thermo Fisher Scientific Inc., incorporated on October 11, 1960, develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery, and diagnostics. The Company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Company serves various markets, such as pharmaceutical and biotech; academic and government; industrial and applied; as well as healthcare and diagnostics. The Company serves its customers through its brands, such as Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services.

The Thermo Scientific brand offers customers in research, diagnostics, industrial, and applied markets a range of analytical instruments, as well as laboratory equipment, software, services, consumables, and reagents. Its portfolio of products includes technologies for mass spectrometry, chromatography, elemental analysis, molecular spectroscopy, sample preparation, informatics, chemical research and analysis, cell culture, bioprocess production, cellular, protein and molecular biology research, allergy testing, drugs-of-abuse testing, therapeutic drug monitoring testing, microbiology, anatomical pathology, as well as environmental monitoring and process control. The Applied Biosystems brand offers customers in research, clinical and applied markets integrated instrument systems, reagents, and software for genetic analysis. Its portfolio includes technologies for genetic sequencing and real-time, digital and end point polymerase chain reaction (PCR), that are used to determine meaningful genetic information in applications, such as cancer diagnostics, human identification testing, and animal health, as well as inherited and infectious disease.

 

Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in Thermo Fisher Scientific Inc. as long as the price is correct and the indicators that I describe in my book The Confident Investor are favorable. Most of the fundamentals of this company are good but there are some concerns. I will be dropping this company from my Watch List as I think there are better investments in the market.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor. You can review the best companies that I have found (and I probably invest my own money in most of these companies) in my Watch List.

How was this analysis of Thermo Fisher Scientific Inc. calculated?

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(access_s2member_level1)]

In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

  • Stock price at the time of the calculation: $205.57
  • Growth: 0.11
  • Current EPS (TTM): $6.14
  • P/E: 33
  • Future EPS Calc: $10.34
  • Future Stock Price Calc: $341.42
  • Target stock price: $211.99

[/s2If]
I hope that this makes you a Confident Investor.